Nu Skin (NUS +2.2%) gets an added boost today from positive comments out of Canaccord's Scott...

|About: Nu Skin Enterprises Inc. (NUS)|By:, SA News Editor

Nu Skin (NUS +2.2%) gets an added boost today from positive comments out of Canaccord's Scott Van Winkle. The analyst says that despite getting lumped in with the Herbalife (HLF) debate, Q1 guidance looks conservative as NUS remains in the "in the midst of a powerful product cycle." The firm reiterates its Buy rating but trims down its price target from $65 to $55.